Literature DB >> 11789358

[Analysis and clinical course of residual lithiasis after shock wave renal treatment].

A Rousaud Baron1, F Millán, F Izquierdo de la Torre, F Rousaud, H López Llauradó, J Martí Malet, P de la Torre Holguera.   

Abstract

OBJECTIVE: Although residual lithiasis after the application of shock waves is a situation that coexists with the procedure, in some cases it can be considered to be a failure of ESWL. The natural history and outcome of 244 cases of residual renal stone followed over a 5-year period are analyzed, and the approach based on a pre-established classification is discussed.
METHODS: Of 1,407 patients treated by ESWL for renal lithiasis during 1995, 244 cases with a renal calculus larger than 3 mm were followed for a period of 5 years after treatment and evaluated by clinical, radiological, ultrasound and analytical methods.
RESULTS: At 3 months post-ESWL, 1,013 cases (72%) were completely stone-free and 394 (28%) showed residual stone; of these, 244 (62%) had residual stone fragments greater than 3 mm. At 5 years, 190 (78%) remained stable and the remaining 54 (22%) showed stone regrowth that warranted additional treatments: 52 ESWL, 1 PNL and 1 partial nephrectomy. Despite the retreatments, only 42% became completely stone-free.
CONCLUSIONS: A classification of residual renal stone can be established based on the data obtained to orient the approach in each case, although the frequency of residual stone can be reduced by the appropriate indication of ESWL. Once a renal stone has formed retreatments with ESWL cannot ensure complete elimination of the stone.

Entities:  

Mesh:

Year:  2001        PMID: 11789358

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  2 in total

1.  Which efficiency index for urinary stones treatment?

Authors:  Gauthier Raynal; Jacques Petit; Fabien Saint
Journal:  Urol Res       Date:  2009-06-10

2.  An experimental study on residual lithiasis after shock wave lithotripsy.

Authors:  A Costa-Bauzá; J Perelló; B Isern; F Grases
Journal:  Urol Res       Date:  2005-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.